NC Life Sciences Organization’s Post

🧬👩🔬The biotech funding ecosystem is critically important to bringing new cures to patients. Helping our startup members access capital and build a network of collaboration partners remains a priority. California Life Sciences (CLS) is proud to support several female-led startup members at the BIO International Convention Startup Stadium @BIO2024. View the presenters at this years Start-Up Stadium here: https://bit.ly/3x4skLm California biotechs garnered $5.03 billion through 157 venture raises in 2023, up from $4.03 billion in 2022. View the California Life Sciences (CLS) Regional Snapshots and learn more about the key life science hubs in CA: https://bit.ly/4aMLhjo

Yesterday, we had the pleasure of attending the Road2 Haifa Bioconvergence for Startups event, where Gil Kerbs, who heads our new investments, participated in the VC panel. 🌟 One key message he shared was that when it comes to bio convergence in healthcare (rather uniquely as compared to other areas), there are many companies in which the concern about the potential market is minimal - if your technology to cure a type of cancer actually works, there are minimal concerns about who would buy it.  Therefore, when entrepreneurs of such companies approach investors, they need to understand how much time, data, and money it will take to verify and prove their technology, and translate it into a fundable milestones - as that would be the #1 concern of investors. 🎯🔬

Biotech Week Boston 2024 is just around the corner, taking place from September 23-26 at the Hynes Convention and Exhibition Center in Boston. We are thrilled to announce that Life Science Nation (LSN) will be hosting the RESI Boston 2024 Conference on September 25 at The Westin Copley Place, just a short 10-minute walk from the Biotech Week venue. Following the in-person conference, a two-day virtual partnering event will be held on September 26-27. RESI Boston will bring together over 300 early-stage life science investors and licensing partners, as well as more than 300 early-stage life science companies. Whether you are a CEO seeking funding, an investor hunting for cutting-edge technologies, or a service provider looking for business opportunities, RESI Boston is an event you cannot afford to miss. 📅 Register by July 5 to take advantage of the Super Early Bird Rates and save $500! Plus, use discount code MKTYZ to receive an additional $100 off. 🔗 RESI Boston Registration: https://cvent.me/ZN4gvn Don't miss out on this incredible opportunity to connect, network, and propel your business forward. See you in Boston! #BiotechWeekBoston #RESIBoston #LifeScience #Investors #Startups #Networking #Innovation #Biotech #Healthcare #Pharma #Entrepreneurship #BostonEvents #BusinessGrowth #Partnering #Investment #RESI #LSN #LifeScienceNation

Join me tonight to learn more about these interesting and exciting early stage companies!

Looking forward to being part of this Programme on 24th October to talk about the challenges and key growth drivers on the commercialisation journey and hearing from the other experts. See details below to book. #innovation #commercialisation #growthstrategy

Thrilled to speak with two incredible groups this week at Johns Hopkins University to share insights from my work founding Aptabridge Therapeutics, Inc.. I left that night feeling energized and grateful. I was invited to engage with early entrepreneurs and students through the #FastForwardU FUEL Accelerator and a master's-level course titled "The Biotech Enterprise," expertly led by Professor Rudnick. Our discussions covered several essential topics for hard tech founders, like how to identify #innovation, strategies to operationalize it, the macroeconomics of public/private partnerships, and strategies for value creation. Sharing the stage with Evan H., CEO of CurveAssure, is always a highlight. Our unique perspectives, coming from therapeutics versus medical devices, bring out depth and richness to these critical discussions that always leave me with new ideas. After an already engaging late class, several students stayed back to ask more questions. Their excitement was so infectious that we had to get a photo. It's clear the entrepreneurial spirit is thriving, especially in #biotech and #lifesciences, and I'm happy to be a part of this vibrant ecosystem. Key takeaways: 1. Identify the whats and whos that deeply energize you. Seek them out. 2. Commit to hard, focused work on what truly matters. Trust the process. 3. Proactively build and nurture your network. Best to build the well before your thirsty. #Entrepreneurship #JohnsHopkins #Networking #StartupLife #FFU #HappyInnovating Don't miss the FUEL cohort's Demo Day on May 3rd at Johns Hopkins! It's a fantastic opportunity to see these impressive entrepreneurs in action. https://lnkd.in/e-MDNVVH

🚀 Calling all MedTech and Life Science Founders! 🚀 Are you wondering why you should attend Austin MedTech Connect’s next Focus on the Founder on Wednesday, October 23rd at Capital Factory? Here’s why this event is a must-attend: 💡 Gain Critical Insights: Hear from leading experts on what investors are truly looking for. Discover how to refine your market strategy and business model for success! 🤝 Network with Key Players: Connect with clinicians, investors, and industry veterans who can provide valuable feedback and guidance on your journey. 🗣️ Pitch Your Vision: Seize the opportunity to present your startup during 1-minute pitches and receive direct insights from those who know what it takes to succeed in the healthcare landscape. 🔗 Access Valuable Resources: Learn about essential tools and support systems designed to help startups thrive in the competitive MedTech environment. Don’t miss this chance to refine your approach, expand your network, and gain the confidence you need to secure funding! Registration link is in the comments👇 Jawad Ali, MD 🔪 Jeff Levine Kristin Norton, PhD Jameil ‘Jay’ Pendleton™ Zain Kazmi Zubin Shah April Zambelli-Weiner, Ph.D. Fernanda Nusbaum Jason Partridge TTi Health Research & Economics Green Room Business Solution Partners Ashley Dostie

🎉 We are so proud to announce that we have been selected from hundreds of companies by EU to participate in the #EUeic USA Soft - Landing Program for Health and Life Sciences, scheduled from May 19 to 24, 2024, in Silicon Valley. This program is designed to support high-potential European startups in accessing the US markets and investor networks. Find our more in our press release 🙌 #braininjury #medtech #strokediagnosis #medtechinnovation #EUeic

We’re delighted to have Pam Garside, chair of Cambridge Angels with us this week. Pam gives us an introduction to Cambridge Angels and their focus areas - #DeepTech #AI #SpaceTech #DigitalHealth #HealthTech #BioTech. Interestingly, members attract deals. Pam alone receives 2 decks a day. In total they see 1000 deals per year, expertly triaged by deal sorcerer Emmi Nicholl. Interesting candidates are then offered the opportunity to pitch. The members invest as individuals, not as a collective fund, and within the group – one investor will usually be a deal lead and may take a seat on the board. It’s a really engaging way of entrepreneurs funding entrepreneurs. Some of their portfolio companies include: Paragraf®, Arecor Therapeutics plc, Privitar, abcam, 10to8, Arachnys, FLUSSO LIMITED, Unlikely AI, Monument Therapeutics, Kalium Health, Qureight, Spotta. Pam shares her priorities as chair of the Cambridge Angels ‘network’: 1. ‘Don’t screw it up’ in a difficult market environment 2. Add diversity (a challenge for the UK Investor Community) 3. Raise the profile of depth of expertise of members. We learn about Pam’s unique background, and her journey into investing. And we talk about healthcare and how AI and automation is revolutionising the sector but requires caution – it’s not an area to ‘move fast and break things’ as Mark Zuckerberg advises! Trends to watch - #ComputationalBiology, #Genomics, #PersonalisedMedicine, #Oncology, #Biomarkers, #GeneticProfiling and out of the University of Cambridge #ClimateTech #Sustainability #CamTechPod Durham University, Imperial College, Cambridge Judge Business School, Peter Cowley (he/him), Simon Thorpe, Robert Sansom, David Cleevely CBE FREng FIET, Beauhurst, Simon Blakey, Jonathan Milner, Sherry Coutu CBE, Amy Weatherup (she/her), William Tunstall-Pedoe FREng, Jenny Tooth OBE, UK Business Angels Association, Angel Academe - increasing female investment, Kheiron Medical, DeepMind, The Trinity Bradfield Prize, Cambridge Enterprise Cambridge Enterprise Ventures

🌟 Exciting News! 🌟 Please join us in welcoming Dr. Karolina Valente from VoxCell BioInnovation as one of our newest Ventures in the Growth initiative! We’re thrilled to have Karolina and her team on board and can’t wait to see their continued success unfold. Check out Karolina's message below to hear what she’s most excited about as she embarks on this journey with us. ✨ #WomenInTech #FemaleFounders #TechEntrepreneurs #StartupWomen #WomenInBusiness #FemaleEntrepreneurs